Innovotech Inc.
TSX VENTURE : IOT

Innovotech Inc.

October 15, 2008 06:00 ET

Innovotech Strengthens Product Development Capability With ISO Accreditation

EDMONTON, ALBERTA--(Marketwire - Oct. 15, 2008) - The International Organization for Standardization (ISO) has approved Innovotech's (TSX VENTURE:IOT) quality system for medical device manufacture, meaning that it meets the exceptionally high international standards of ISO 13485:2003. This accreditation will augment the safety and operational infrastructure that Innovotech is building to support its first medical device product, bioFILM PA™. Achieving this milestone gives Innovotech greater freedom to fully exploit the manufacturing and market potential for bioFILM PA™ and related products that Innovotech is developing.

"Hospitals and diagnostic laboratories can use bioFILM PA™ with the comfort that the product meets Health Canada regulatory standards and the high quality standards required by ISO 13485:2003", says Dr. Bhavin Rawal, Product Manager - bioFILM PA™. "This accreditation will provide the company with full control over the supply chain including in-house manufacturing of bioFILM PA™".

The audit for Innovotech's ISO certification was completed by Intertek, an independent Standards Council of Canada accredited registrar.

About Innovotech Inc:

Innovotech is a product development company focusing on the development of solutions to medical, agricultural and industrial problems caused by microbial biofilms. Biofilms are protected communities of microorganisms which are very common and very difficult to treat due to their inherent resistance. They have been implicated in a host of devastating infections in agriculture, human health and industry. No diagnostics or antibiotics are currently approved for use in infections involving biofilms.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information